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Abstract
Introduction Septic renal failure is often seen in the intensive
care unit but its pathogenesis is only partly understood. This
study, performed in a normotensive rat model of endotoxemia,
tests the hypotheses that endotoxemia impairs renal
microvascular PO2 (µPO2) and oxygen consumption (VO2,ren),
that endotoxemia is associated with a diminished kidney
function, that fluid resuscitation can restore µPO2, VO2,ren and
kidney function, and that colloids are more effective than
crystalloids.
Methods Male Wistar rats received a one-hour intravenous
infusion of lipopolysaccharide, followed by resuscitation with
HES130/0.4 (Voluven®), HES200/0.5 (HES-STERIL® ® 6%) or
Ringer's lactate. The renal µPO2 in the cortex and medulla and
the renal venous PO2 were measured by a recently published
phosphorescence lifetime technique.
Results Endotoxemia induced a reduction in renal blood flow
and anuria, while the renal µPO2 and VO2,ren remained relatively
unchanged. Resuscitation restored renal blood flow, renal
oxygen delivery and kidney function to baseline values, and was
associated with oxygen redistribution showing different patterns
for the different compounds used. HES200/0.5 and Ringer's
lactate increased the VO2,ren, in contrast to HES130/0.4.
Conclusion The loss of kidney function during endotoxemia
could not be explained by an oxygen deficiency. Renal oxygen
redistribution could for the first time be demonstrated during
fluid resuscitation. HES130/0.4 had no influence on the VO2,ren
and restored renal function with the least increase in the amount
of renal work.
Introduction
The kidney is one of the most commonly injured organs in crit-
ically ill patients. Acute renal failure is a complication in sepsis,
with a prevalence ranging from 25% in severe sepsis to 50%
in septic shock [1]. Sepsis seems to have an additional impact
on outcome, as mortality can be up to 75% among patients
with acute septic renal failure [2,3]. The pathogenesis of sep-
sis-induced renal failure is multifactorial and is characterized
by a reduction in the glomerular filtration rate that may occur
despite a maintained renal blood flow (RBF) and normal sys-
temic hemodynamics [4].
The morphology of the kidney can range from normal appear-
ing tissue to endothelial damage, medullary blockade with
tubular necrosis and disseminated fibrin thrombi [5]. Theories
on the pathogenesis suggest an uncontrolled and inappropri-
ate release of various inflammatory mediators leading to direct
cytotoxic effects or an impairment of the microvascular
autoregulation [6]. The latter might cause a maldistribution of
renal microcirculatory blood flow and oxygen supply. Regard-
ing renal tissue oxygenation, there is a high heterogeneity of
oxygen tensions within the organ due to the anatomy of the
renal microvasculature [7,8]. The fact that not all regions within
the kidney are equally well provided with oxygen makes the
organ rather sensitive to hypoxic injury [9]. The few studies
that have investigated changes in renal tissue oxygenation dur-
ing endotoxemia present contrasting results [10-12]. The rela-
tionship between renal oxygen delivery, consumption and
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tissue oxygenation, especially with regard to biological
response and functional consequences, is still poorly under-
stood and the role of oxygen in septic renal failure remains
controversial [10,13,14].
Fluid resuscitation is an early therapeutic strategy in the treat-
ment of septic shock, with the aim of restoring blood flow and
oxygen delivery to vital organs [15]. The decision of which
solution should be used during resuscitation remains contro-
versial, especially with regard to the kidney. There is an ongo-
ing discussion about the potential of hydroxyethyl starches to
impair renal function [16-18]. In well-hydrated patients without
preexisting renal dysfunction, however, application of starches
seems to be safe [19,20]. Fluid resuscitation not only has an
influence on systemic hemodynamics but also dilutes the
blood, resulting in beneficial effects on the microvasculature
[21,22].
A recently published study from our group demonstrates that
resuscitation with HES200/0.5 (HES-STERIL®  6%) could
successfully restore a decreased mucosal microvascular PO2
(µPO2) of the pig's intestine after lipopolysaccharide (LPS)
infusion [23]. In contrast to the mucosal µPO2, the serosal
µPO2 remained decreased. The gut mucosa and serosa can
be regarded as two differently behaving anatomical compart-
ments, and the same accounts for the kidney cortex and the
kidney medulla. The renal tissue PO2 is regionally different,
with values around 50 Torr (6.7 kPa) in the cortex and 20 Torr
(2.7 kPa) in the medulla [9]. As the tissue PO2 reflects the bal-
ance between oxygen delivery and consumption of oxygen in
viable cells and tissues [24], its observation in a model of sep-
tic renal failure can give important information, particularly
because renal hypoxia seems to play an important role in the
pathogenesis of the disease [9,25].
The primary objective of the present study is to test the hypoth-
esis that treatment of endotoxemia by fluid resuscitation with
either colloids or crystalloids improves an impaired µPO2,
resulting in restoration of oxygen consumption and kidney
function. Secondary to the primary objective our study involves
a detailed description of changes in oxygenation during endo-
toxemia and a comparison of different resuscitation fluids. Four
distinct hypotheses can be identified: that renal µPO2 and oxy-
gen consumption are impaired during endotoxemia; that this
effect is associated with a diminished renal function; that fluid
resuscitation with either colloids or crystalloids improves an
impaired µPO2 and oxygen consumption and restores kidney
function; and that colloids are better at resuscitating than crys-
talloids in this context.
In the present study we applied a new technique recently
developed and validated by our group [26] to a normotensive
rat model of endotoxemia. This phosphorescence quenching
technique allows the noninvasive quantitative measurement of
cortical microvascular PO2 (cµPO2) and medullary microvas-
cular PO2 (mµPO2) and the detection of the renal venous PO2
(PrvO2). A continuous noninvasive measurement of renal oxy-
gen consumption has been made possible with this unique
possibility. Furthermore, we determined the glomerular filtra-
tion rate and tubular sodium reabsorption, the major energy-
consuming and therefore oxygen-consuming process in the
kidney.
Materials and methods
Animals
All experiments in this study were approved and reviewed by
the Animal Research Committee of the Academic Medical
Center at the University of Amsterdam. Care and handling of
the animals were in accordance with the guidelines for Institu-
tional and Animal Care and Use Committees. Experiments
were performed on 37 Wistar male rats (Charles River, Maas-
tricht, The Netherlands) with a mean ± standard deviation
body weight of 282 ± 16 g.
Surgical preparation
Rats were anesthetized with an intraperitoneal injection of a
mixture of 90 mg/kg ketamine (Nimatek®; Eurovet, Bladel, The
Netherlands), 0.5 mg/kg medetomidine (Domitor®; Pfizer,
New York, NY, USA) and 0.05 mg/kg atropine-sulfate (Centra-
farm, Etten-Leur, The Netherlands). After tracheotomy the ani-
mals were mechanically ventilated with a FiO2 of 0.4. For drug
and fluid administration, four vessels were cannulated with pol-
yethylene catheters (outer diameter, 0.9 mm; Braun, Melsun-
gen, Germany).
A catheter in the right carotid artery was connected to a pres-
sure transducer to monitor the arterial blood pressure and the
heart rate. The right jugular vein was cannulated and the cath-
eter tip inserted to a depth close to the right atrium, allowing
continuous central venous pressure measurement. Catheters
of the same size were placed in the right femoral artery and
vein and were used for withdrawal of blood and continuous
infusion of Ringer's lactate at a rate of 15 ml/kg/hour (Baxter,
Utrecht, The Netherlands). The body temperature of the rat
was maintained at 37 ± 0.5°C during the entire experiment.
The ventilator settings were adjusted to maintain an arterial
PCO2 between 35 and 40 Torr (4.7–5.3 kPa). All preceding
steps were described in detail in a previous study [27].
The kidney was exposed, decapsulated and immobilized in a
Lucite kidney cup (K. Effenberger, Pfaffingen, Germany) via a
4 cm incision of the left flank. The renal vessels were carefully
separated from each other under preservation of the nerves. A
0.5 × 1.0 cm2 piece of aluminum foil was placed on the dorsal
site of the renal vein to prevent contribution of underlying tis-
sue to the phosphorescence signal in the venous PO2 meas-
urement. A perivascular ultrasonic transient time flow probe
(type 0.7 RB; Transonic Systems Inc., Ithaca, NY, USA) was
placed around the left renal artery and connected to a flow
meter (T206; Transonic Systems Inc.) to allow continuousAvailable online http://ccforum.com/content/10/3/R88
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measurement of RBF [28]. The left ureter was isolated, ligated
and cannulated with a polyethylene catheter for urine collec-
tion. The operation field was covered with plastic foil through-
out the entire experiment, to prevent evaporation of body
fluids. The experiment was ended by infusion of 1 ml of 3 M
potassium chloride inducing a sudden cardiac arrest. Finally,
the kidney was removed and weighed, and correct placement
of the catheters was checked post mortem.
Hemodynamic and blood gas measurements
The mean arterial pressure (MAP) was continuously measured
in the carotid artery, calculated as: MAP (mmHg) = diastolic
pressure + (systolic pressure – diastolic pressure)/3. Further-
more the blood flow of the renal artery (ml/minute) was meas-
ured and recorded continuously.
An arterial blood sample (0.2 ml) was taken from the femoral
artery at three different time points: first time point, 0 minutes
Table 1
Systemic hemodynamics
Baseline (t0) Endotoxemia (t1) Resuscitation (t2)
Mean arterial blood pressure (mmHg)
Nonresuscitation group 117 ± 6 105 ± 13† 96 ± 19*†
HES130/0.4 (Voluven®) group 118 ± 6 102 ± 21† 96 ± 26*†
HES200/0.5 (HES-STERIL® 6%) group 119 ± 9 105 ± 11† 114 ± 14
Ringer's lactate group 113 ± 10 102 ± 18† 123 ± 26
Control group 113 ± 4 127 ± 3* 129 ± 6*‡
Heart rate (beats/minute)
Nonresuscitation group 263 ± 21 278 ± 27† 294 ± 30*†
HES130/0.4 (Voluven®) group 268 ± 25 277 ± 22† 299 ± 24*†
HES200/0.5 (HES-STERIL® 6%) group 252 ± 16 269 ± 27* 295 ± 16*†
Ringer's lactate group 247 ± 14 264 ± 26* 280 ± 19*†
Control group 261 ± 9 248 ± 9* 256 ± 7‡
Central venous pressure (mmHg)
Nonresuscitation group 3.8 ± 1.3 3.9 ± 0.6 3.7 ± 0.8
HES130/0.4 (Voluven®) group 4.0 ± 0.9 4.0 ± 0.9 6.3 ± 1.2*†‡
HES200/0.5 (HES-STERIL® 6%) group 4.2 ± 0.6 3.9 ± 0.6 6.0 ± 1.5*‡
Ringer's lactate group 3.8 ± 0.9 4.0 ± 1.4 6.7 ± 1.7*†‡
Control group 4.2 ± 0.9 4.5 ± 1.8 4.6 ± 1.1
Renal blood flow (ml/minute)
Nonresuscitation group 4.9 ± 0.9 2.5 ± 1.1*† 2.1 ± 1.3*†
HES130/0.4 (Voluven®) group 4.8 ± 1.0 2.1 ± 0.9*† 4.9 ± 1.5‡
HES200/0.5 (HES-STERIL® 6%) group 5.4 ± 1.0 2.0 ± 0.7*† 6.7 ± 1.1*†‡
Ringer's lactate group 4.9 ± 0.9 3.0 ± 1.2*† 5.7 ± 1.3*‡
Control group 5.6 ± 0.9 5.1 ± 1.0 5.1 ± 1.0‡
Renal vascular resistance (dyne/s/cm5)
Nonresuscitation group 26 ± 6 50 ± 22*† 51 ± 22*†
HES130/0.4 (Voluven®) group 25 ± 6 58 ± 32* 21 ± 8‡
HES200/0.5 (HES-STERIL® 6%) group 23 ± 5 57 ± 22*† 17 ± 1†‡
Ringer's lactate group 24 ± 7 38 ± 9*† 21 ± 2†‡
Control group 21 ± 3 26 ± 5* 26 ± 5*‡
Values presented as the mean ± standard deviation. *P < 0.05 versus baseline, †P < 0.05 versus control group, ‡P < 0.05 versus nonresuscitation 
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= baseline (t0); second time point, 50 minutes = endotoxemia
(t1); and third time point, ~70 minutes = resuscitation (t2). The
blood samples were replaced by the same volume of
HES130/0.4 (Voluven®, 6% HES 130/0.4; Fresenius Kabi
Nederland B.V., Schelle, Belgium). The samples were used for
determination of blood gas values (ABL505 blood gas ana-
lyzer; Radiometer, Copenhagen, Denmark), as well as for
determination of the hematocrit concentration, hemoglobin
concentration, hemoglobin oxygen saturation, and sodium and
potassium concentrations (OSM 3; Radiometer).
Measurement of renal microvascular oxygenation and 
renal venous PO2
Oxygen-dependent quenching of phosphorescence was used
to detect changes in µPO2 and to measure the PO2 in the renal
vein (PrvO2). In brief, after infusion a water-soluble phospho-
rescent dye (Oxyphor G2; Oxygen Enterprises, Ltd. Philadel-
phia, PA, USA) binds to albumin. This phosphor-albumin
complex is confined to the circulation and emits phosphores-
cence with a wavelength around 800 nm, if excited by a flash
of light [29]. The phosphorescence intensity decreases at a
rate dependent on the surrounding oxygen concentration. The
relationship between the measured decay time and the PO2 is
given by the Stern-Volmer relation: 1/τ = (1/τ0) + kq [O2],
where τ is the measured decay time, τ0 is the decay time at an
oxygen concentration of zero and kq is the quenching constant.
For oxygenation measurements within the rat renal cortex and
the outer medulla, a dual-wavelength phosphorimeter was
used. This new method was recently described and validated
elsewhere [26]. Oxyphor G2 (a two-layer glutamate dendrimer
of tetra-(4-carboxy-phenyl) benzoporphyrin) gets excited with
light of 440 nm and 632 nm, respectively, which allows a con-
tinuous and simultaneous measurement in two different
depths, the kidney cortex and the outer medulla. On the basis
of a high tissue penetration and the fact of the low light
absorbance of blood within the near-infrared spectrum, Oxy-
phor G2 is also well suited for oxygen measurements in full
blood. Using a frequency-domain phosphorimeter and a very
thin reflection probe, the technique of oxygen-dependent
quenching of phosphorescence was applied for noninvasive
detection of the PrvO2.
Calculation of renal oxygen delivery, renal oxygen 
consumption, renal oxygen extraction and vascular 
resistance
Renal oxygen delivery was calculated as DO2ren (ml/minute) =
RBF × arterial oxygen content (1.31 × hemoglobin × SaO2) +
(0.003 × PaO2), where SaO2 is arterial oxygen saturation and
PaO2 is arterial partial pressure of oxygen.
Renal oxygen consumption was calculated as VO2ren (ml/
minute/g) = RBF × (arterial – renal venous oxygen content
difference).
Renal venous oxygen content was calculated as (1.31 ×
hemoglobin × SrvO2) + (0.003 × PrvO2). The SrvO2 was calcu-
lated using Hill's equation with p50 = 37 Torr (4.9 kPa) and
Hill coefficient = 2.7 [30].
The renal oxygen extraction ratio was calculated as O2ERren
(%) = VO2ren/DO2ren.
Since values of renal venous pressure were not available, an
estimation of the vascular resistance of the renal artery flow
region was made: MAP – RBF ratio (U) = (MAP/RBF) × 100
[31].
Assessment of kidney function
Creatinine clearance (Clearcrea) was assessed as an index of
the glomerular filtration rate according to the standard proce-
dure to measure the function of the investigated kidney
Figure 1
Example experiment Example experiment. Lipopolysaccharide (LPS) infusion resulted in a slight initial decline in the mean arterial pressure (MAP) and a marked 
decrease in renal blood flow (RBF). Whereas the MAP recovered after 20 minutes, the RBF remained unchanged. Fluid resuscitation with 6 ml 
HES130/0.4 restored RBF to 20% above baseline values. Cortical (cµPO2) and medullary (mµPO2) microvascular PO2 did not change during LPS 
infusion. Upon fluid resuscitation cµPO2 markedly decreased.Available online http://ccforum.com/content/10/3/R88
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[13,32]. Calculations of the clearance were made with the
standard formula: clearance (ml/minute) = (U × V)/P, where U
is the urine concentration of creatinine, V is the urine volume
per unit time and P is the plasma concentration of creatinine.
The specific elimination capacity for creatinine of the left kid-
ney was normalized to the organ weight. Urine samples from
Figure 2
Measured renal oxygenation parameters Measured renal oxygenation parameters. (a) Cortical microvascular PO2 (µPO2), (b) medullary µPO2 and (c) renal venous PO2 at baseline (t0), 
endotoxemia (t1) and resuscitation (t2) in the control (C) group (n = 5), nonresuscitation (NR) group (n = 8), HES130/0.4 resuscitation group (n = 
8), HES200/0.5 resuscitation group (n = 8) and Ringer's lactate (RL) resuscitation group (n = 8). *P < 0.05 versus baseline, #P < 0.05 versus con-
trol group, •P < 0.05 versus NR group. Rats are individually presented and connected by lines.Critical Care    Vol 10 No 3    Johannes et al.
Page 6 of 13
(page number not for citation purposes)
Figure 3
Calculated renal oxygenation parameters Calculated renal oxygenation parameters. (a) Renal oxygen delivery (DO2ren), (b) renal oxygen consumption (VO2ren) and (c) renal oxygen extrac-
tion (O2ERren) at baseline (t0), endotoxemia (t1) and resuscitation (t2) in the control (C) group (n = 5), nonresuscitation (NR) group (n = 8), HES130/
0.4 resuscitation group (n = 8), HES200/0.5 resuscitation group (n = 8) and Ringer's lactate (RL) resuscitation group (n = 8). *P < 0.05 versus 
baseline, #P < 0.05 versus control group, •P < 0.05 versus NR group. Rats are individually presented and connected by lines.Available online http://ccforum.com/content/10/3/R88
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the left ureter were collected at 10-minute intervals for analysis
of urine volume and creatinine concentration. Plasma samples
for analysis of creatinine were obtained at the midpoint of each
10-minute urine collection period. The concentrations of cre-
atinine in urine and plasma were determined by colorimetric
methods.
Furthermore, all urine samples were analyzed for the sodium
concentration. The urine sodium concentration (UNa+; mmol/l)
was multiplied by the urine volume per unit time to obtain
sodium excretion (UNa+ × V). The cost of sodium transport
(VO2/TNa+) is the ratio of the total amount of VO2ren over the
total amount of sodium reabsorbed (TNa+, mmol/minute),
which was determined according to: TNa+ = (Clearcrea × PNa+)
- UNa+ × V, where PNa+ is the plasma sodium concentration.
Experimental protocol
After an operating time of 60 minutes, two optical fibers for
phosphorescence measurements were placed both 1 mm
above the decapsulated kidney surface and 1 mm above the
renal vein. Oxyphor G2 (1.2 ml/kg; Oxygen Enterprises, Ltd)
was subsequently infused intravenously for 15 minutes. After
40 minutes µPO2 and PrvO2 were continuously measured dur-
ing the entire experiment, and 10 minutes later the baseline
blood sample (0.2 ml) was taken via the femoral artery cathe-
ter. At this time point the rats were randomized between the
nonresuscitation group (n  = 8), the resuscitation with
HES130/0.4 group (n = 8), the resuscitation with HES200/
0.5 group (n = 8), the resuscitation with Ringer's lactate group
(n = 8), and the control group (n = 5).
In total 32 animals were assigned to receive a one-hour infu-
sion of LPS (10 mg/kg, serotype 0127:B8; Sigma-Aldrich,
Zwijndrecht, the Netherlands) to induce endotoxemia. Five ani-
mals served as time controls. A second blood sample was
taken 50 minutes after the start of LPS infusion and was ana-
lyzed as already described. Directly after cessation of LPS
infusion, one group of animals received fluid resuscitation with
Voluven® (6% HES 130/0.4; Fresenius Kabi) at a rate of 20
ml/hour. For all resuscitation groups the resuscitation target
was defined as a five-minute steady plateau in RBF. A second
group of rats received fluid resuscitation with HES200/0.5
(HES-STERIL®, 6% HES 200/0.5; Fresenius Kabi) at a rate of
20 ml/hour. A third group of animals received Ringer's lactate
(Baxter) as the resuscitation fluid; to ensure the same volume
effect, the infusion rate was 60 ml/hour. A fourth group served
as controls and did not receive fluid resuscitation after LPS
infusion.
The experiment was ended 10 minutes after cessation of fluid
resuscitation or at a corresponding time point for the control
groups by intravenous bolus injection of 3 M KCl.
Statistical analysis
Values are reported as the mean ± standard deviation, unless
indicated otherwise. The decay curves of phosphorescence
were analyzed using Labview 6.1 software (National Instru-
ments, Austin, TX, USA). Statistics were performed using
GraphPad Prism version 4.0 for Windows (GraphPad Soft-
ware, San Diego, CA, USA). Differences within groups were
first tested with the one-way analysis of variance for repeated
measurements. When appropriate, post-hoc  analyses were
performed with the Student-Newman-Keuls post test. Inter-
group differences were analyzed using the unpaired t test. P <
0.05 was considered significant.
Results
Systemic variables
Systemic hemodynamic changes for the time points of base-
line (t0), endotoxemia (t1) and resuscitation (t2) are presented
in Table 1. Baseline values in the experimental and control
groups were no different. LPS infusion induced a slight
decrease in the MAP compared with the control group. Resus-
citation with HES200/0.5 (HES-STERIL® 6%) and Ringer's
lactate restored the MAP to baseline values, whereas after
resuscitation with HES130/0.4 (Voluven®) the MAP remained
at 96 ± 26 mmHg. Although the MAP significantly increased
in the time control group to 129 ± 6 mmHg at t2, all groups
showed normotensive values during the entire experiment.
After LPS infusion the heart rate increased significantly from
263 ± 21 beats/minute at t0 to 294 ± 30 beats/minute at t2 in
the nonresuscitation group. The heart rate increased in all
groups receiving fluid resuscitation (versus baseline and con-
trol values, P < 0.05). Fluid resuscitation also increased the
central venous pressure significantly regardless of the type of
fluid.
The RBF decreased dramatically during LPS infusion to 50%
of baseline values and did not recover in the nonresuscitation
group. Both resuscitation with colloids and crystalloid
restored the RBF to baseline values. After a sudden decrease
in RBF from 5.4 ± 1.0 to 2.0 ± 0.7 ml/minute with LPS infu-
sion, HES200/0.5 restored the RBF most effectively to 6.7 ±
1.7 ml/minute (versus baseline and control values, P < 0.05).
The calculated renal vascular resistance showed a 50%
increase from 26 ± 6 dyne/s/cm5 at baseline to 51 ± 22 dyne/
s/cm5 at t2 in the nonresuscitation group. This increase in renal
vascular resistance was present in all groups receiving LPS
and could be normalized to baseline values with fluid
resuscitation.
The pH remained 7.4 at all time points in the control group.
The pH decreased in all groups receiving LPS from 7.4 at
baseline, to 7.3 at t1 and to 7.2 at t2. Fluid resuscitation could
not preserve this drop in pH. The negative base excess
decreased from -2.1 ± 2.2 mmol/l for all experimental groupsCritical Care    Vol 10 No 3    Johannes et al.
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Figure 4
∆PO2 between cortical and medullary microvascular PO2 calculated as a measure of oxygen redistribution ∆PO2 between cortical and medullary microvascular PO2 calculated as a measure of oxygen redistribution. Cortical microvascular PO2 
(cµPO2) and medullary microvascular PO2 (mµPO2) are shown for baseline (t0), endotoxemia (t1) and resuscitation (t2) in (a) control (C) group (n = 
5), (b) nonresuscitation (NR) group (n = 8), (c) HES130/0.4 resuscitation group (n = 8), (d) HES200/0.5 resuscitation group (n = 8) and (e) 
Ringer's lactate (RL) resuscitation group (n = 8). *P < 0.05 versus baseline, #P < 0.05 versus control group, •P < 0.05 versus NR group. Data pre-
sented as mean ± standard deviation. µPO2, microvascular PO2. ∆PO2, the difference in cµPO2 and mµPO2.Available online http://ccforum.com/content/10/3/R88
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at t0 to -8.4 ± 2.4 mmol/l at t1. A further drop to -12.2 ± 6.0
mmol/l in the nonresuscitation group could be prevented by
fluid resuscitation.
The resuscitation target for all groups receiving fluid resuscita-
tion was defined as a five-minute steady plateau in RBF. On
completion of the experiment, animals resuscitated with
HES130/0.4 and HES200/0.5 received an average amount of
5.8 ± 1.3 and 8.0 ± 1.1 ml fluids, respectively, until a plateau
in RBF was reached. To reach the same resuscitation target
and volume effect, 23.0 ± 4.5 ml Ringer's lactate were admin-
istered. Hematocrit values did not change in the control
groups. With fluid resuscitation the hematocrit decreased
about 21%, 23% and 16% for HES130/0.4, HES200/0.5 and
RL, respectively, compared with baseline values.
An example of an experiment is shown in Figure 1. The MAP
and RBF started to decrease with the onset of LPS infusion.
While the MAP dropped only slightly and began to recover to
baseline values after 20 minutes, the RBF remained
decreased at 50% of baseline. Resuscitation with HES130/
0.4 restored RBF to values ~20% above baseline. The cµPO2
and the mµPO2 only slightly changed during the one-hour LPS
infusion. With the onset of fluid resuscitation there was a redis-
tribution of cortical oxygenation towards the medulla.
Renal oxygenation
Data of the oxygenation parameters of the kidney are shown in
Figures 2, 3, 4. Baseline values in the experimental and control
groups were not significantly different. The cµPO2 and mµPO2
decreased significantly during the experiment in all groups:
from 71 ± 8 Torr (9.5 ± 1.1 kPa) at t0 to 53 ± 9 Torr (7.1 ± 1.2
kPa) at t2 for the cµPO2, and from 54 ± 5 Torr (7.2 ± 0.7 kPa)
at t0 to 43 ± 10 Torr (5.7 ± 1.3 kPa) at t2 for the mµPO2. LPS
infusion had no effect on microvascular oxygenation. The med-
ullary PO2 could be significantly restored in animals receiving
resuscitation with HES200/0.5 (versus baseline and control
values, P < 0.05).
The PrvO2 was significantly lower at t2 than at baseline in all
groups except the HES130/0.4 group. In the group receiving
HES130/0.4, the PrvO2 increased in 50% of the animals and
the PrvO2 was unchanged or decreased in the other 50%,
explaining a rather high standard deviation. Although no major
changes in renal µPO2 occurred, fluid resuscitation regardless
of the type of fluid was accompanied by redistribution
between the cortical and medullary PO2. This redistribution is
demonstrated as changes in ∆PO2  (shown in Figure 4),
defined as the difference in cµPO2  and mµPO2. cµPO2
decreased whereas mµPO2 was unchanged in animals receiv-
ing HES130/0.4, resulting in a ∆PO2 of 9 ± 5 Torr (1.2 ± 0.7
kPa), which was significantly lower compared with baseline
and with the control group (∆PO2 12 ± 5 Torr (1.6 ± 0.7 kPa)).
In the HES200/0.5 and Ringer's lactate groups, the ∆PO2 was
7 ± 3 Torr (0.9 ± 0.4 kPa) respectively. When resuscitated
with HES200/0.5 both the cµPO2  and mµPO2  increased
(mµPO2 > cµPO2), whereas when receiving Ringer's lactate
the cµPO2  decreased and the mµPO2  stayed almost
unchanged.
In the experimental groups DO2ren decreased immediately dur-
ing LPS infusion. In the nonresuscitation group DO2ren
decreased from 1.15 ± 0.25 ml/minute at baseline to 0.58 ±
0.23 ml/minute at t1, and reached its lowest reading with 0.45
± 0.27 ml/minute at t2. Fluid resuscitation restored DO2ren to
~0.93 ml/minute, which was slightly but significantly lower
than baseline values.
VO2ren significantly increased over time from 0.10 ± 0.02 at
baseline to 0.18 ± 0.05 ml/minute/g at t2 in the control group.
This increase was not present in animals receiving LPS, in
whom VO2ren remained around 0.10 ml/minute/g. Fluid resus-
citation with HES200/0.5 and Ringer's lactate significantly
increased VO2ren to 0.18 ± 0.06 ml/minute/g and 0.29 ± 0.22
ml/minute/g, respectively (versus nonresuscitation, P < 0.05).
Resuscitation with HES130/0.4 had no effect on the renal oxy-
gen consumption. Resuscitation with HES200/0.5 and
Ringer's lactate let to a marked increase in O2ERren compared
with the nonresuscitation group – in contrast to HES130/0.4,
which showed no statistical difference.
Renal function
The Clearcrea of the left kidney did not change over the time in
control rats. In the experimental groups the averaged Clearcrea
was 0.78 ± 0.31 ml/minute/g left kidney weight. The averaged
weight of the left kidney was 1.26 ± 0.10 g. At time point t1 all
animals receiving LPS were anuric. Fluid resuscitation by all
tested fluids restored Clearcrea to baseline values, as pre-
sented in Figure 5.
The baseline values for reabsorptive metabolic costs (VO2/
TNa+) were similar in all experimental groups. In the control
group the VO2/TNa+ quotient was slightly lower then in the
other groups and increased nonsignificantly over the time.
With resuscitation VO2/TNa+ trended upwards in all groups. In
animals receiving Ringer's lactate the VO2/TNa+ increased
from 1.21 ± 0.42 at t0 to 2.34 ± 0.87 at t2, which was statisti-
cally significant (data shown in Figure 6).
Discussion
The main findings in our study can be summarized as follows.
Endotoxemia severely diminished renal function despite hav-
ing only a minimal effect on the renal cµPO2 and mµPO2 and
on renal oxygen consumption. Fluid resuscitation restored
renal blood flow and re-established kidney function accompa-
nied this by redistribution of µPO2. Finally, HES130/0.4 was
the only resuscitation fluid tested that did not significantly
increase VO2ren.Critical Care    Vol 10 No 3    Johannes et al.
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In a normotensive model of endotoxemia we tested four
hypotheses: that renal µPO2 and renal oxygen consumption
are impaired during endotoxemia; that this effect is associated
with a diminished kidney function; that treatment of endotox-
emia by fluid resuscitation with either colloids or crystalloids
can improve an impaired µPO2 and oxygen consumption and
restore kidney function; and that colloids are more beneficial
than crystalloids in this context.
These hypotheses must be partly rejected. As regards the first
two hypotheses, in contrast to previous investigation in our
model, the renal µPO2 and renal oxygen consumption were
only minimally affected during endotoxemia, whereas the kid-
ney function was totally diminished. The loss of kidney function
therefore cannot be explained by an oxygen deficiency. As
hypothesized in the third hypothesis, all resuscitation fluids
restored the RBF and kidney function to baseline values.
Regardless of which resuscitation fluid was used, oxygen
redistribution between the cortex and medulla of the kidney
was observed. HES200/0.5 and Ringer's lactate significantly
increased the renal oxygen consumption, in contrast to
HES130/0.4. Regarding the final hypothesis, as both colloids
and crystalloids restored kidney function to baseline values, it
might be difficult to choose one in favor of the other. Regard-
ing the renal oxygen consumption, however, renal resuscita-
tion with HES130/0.4 might cause the least amount of renal
work.
Administration of LPS was characterized by an increased
heart rate, a slight reduction in MAP, a marked decline in RBF,
an increase in renal vascular resistance, and a reduction in the
glomerular filtration rate resulting in anuria. As the initially
slightly reduced MAP recovered to baseline values within 20
minutes, we define our model as normotensive endotoxemia.
This study has some limitations. First, we used anesthetized
animals, which could affect the hemodynamic response and
renal vascular response to LPS and fluid resuscitation. The
changes in the MAP, heart rate and RBF, however, were qual-
itatively similar to previously published data [13,33,34]. Sec-
ond, we did not measure lactate or cytokine levels to verify the
Figure 5
Creatinine clearance as an index of the glomerular filtration rate Creatinine clearance as an index of the glomerular filtration rate. 
Creatinine clearance measured at baseline (t0), endotoxemia (t1) and 
resuscitation (t2) in the control (C) group (n = 5), nonresuscitation (NR) 
group (n = 8), HES130/0.4 resuscitation group (n = 8), HES200/0.5 
resuscitation group (n = 8) and Ringer's lactate (RL) resuscitation 
group (n = 6). As lipopolysaccharide infusion was regularly associated 
with anuria, no clearance could be calculated for these animals. Data 
were normalized per gram of left kidney weight. Data presented as 
mean ± standard error of the mean.
Figure 6
Kidney oxygen consumption per sodium reabsorbed as an index of met- abolic cost Kidney oxygen consumption per sodium reabsorbed as an index 
of metabolic cost. Oxygen consumption per sodium reabsorbed (VO2/
TNa+) measured at baseline (t0) and resuscitation (t2) in the control (C) 
group (n = 5), nonresuscitation (NR) group (n = 8), HES130/0.4 
resuscitation group (n = 8), HES200/0.5 resuscitation group (n = 8) 
and Ringer's lactate (RL) resuscitation group (n = 6). *P < 0.05 versus 
baseline. Testing was performed using the Student paired t test. Data 
are presented as mean ± standard error of the mean.Available online http://ccforum.com/content/10/3/R88
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septic status. We did, however, observe a continuous
decrease in blood pH, accompanied by an increase in nega-
tive base excess regarded as indicative of sepsis. Third, we
used a continuous infusion of LPS to induce endotoxemia.
This approach is not the same as human septic shock because
our animal model is acute and neglects the effects of disease
progression on organ dysfunction over many hours, a problem
encountered in many animal models of sepsis [35].
Only a few studies have been performed investigating the
behavior of renal tissue oxygenation during endotoxemia. Gul-
lichsen and colleagues [33] observed in dogs that, after endo-
toxin infusion, the cortical PO2  was markedly decreased
despite a transient increase in RBF. During the next hours of
the experiment the cortical PO2 and MAP gradually increased
even though the RBF remained relatively depressed. These lat-
ter results are in agreement with our observations. Investiga-
tions by James and colleagues [11] in mice using electron
paramagnetic resonance oximetry showed an initial decrease
in cortical PO2 and a slight increase in medullary PO2 during
LPS infusion, which recovered to the control values after 40
minutes. This recovery of PO2 in both regions was attributed
to a direct toxic effect of LPS on cellular mitochondrial func-
tion, resulting in decreased oxygen utilization.
Different findings exist about the influence of endotoxemia on
the renal oxygen extraction and oxygen consumption
[13,14,33], and the role of oxygen supply herein is controver-
sial. In dogs [33] and sheep [14], for example, an impaired oxy-
gen extraction and decreased oxygen consumption was
found. In rats, however, oxygen consumption was not impaired
by endotoxemia since the kidney was able to increase the oxy-
gen extraction in the presence of a decreased renal oxygen
delivery [13]. An interesting finding in the latter study was that
oxygen consumption did not decrease while the effective tubu-
lar sodium reabsorption was reduced, indicating that another
oxygen-consuming mechanism was induced in their septic
model.
Overall, our findings are in agreement with these findings by
Heemskerk and colleagues [13]. Oxygen consumption did not
change or was only slightly impaired during endotoxemia and
increased during resuscitation. The latter increase was
accompanied by an increase in the VO2/TNa+ ratio. The causes
of that increase in VO2/TNa+ are unknown, but mitochondrial
dysfunction (uncoupling) cannot be excluded. In our model
µPO2 was well preserved during endotoxemia, indicating that
although DO2ren decreased about 50% this was still sufficient
to maintain adequate oxygenation. In our model, therefore, the
role of oxygen supply on changes in O2ERren and VO2ren is
likely to be limited. Although no significant difference in base-
line oxygenation parameters existed between the groups, it is
clear from Figures 2 and 3 that a fairly large variation existed
between individual animals in all parameters except the
mµPO2. The study of Heemskerk and colleagues [13]
reported individual values in the same manner and showed
similar variations in renal DO2 and VO2 values.
Several studies indicate an intrarenal redistribution in blood
flow from the cortex toward the medulla during endotoxemia
[25,36,37]. This suggests that the renal cortex and medulla
have different responses to endotoxin in animal experiments.
As the renal medulla is especially vulnerable to hypoxia and
ischemia [9], sepsis-induced medullary ischemia has been
suspected as a major mechanism of such renal injury. In our
model the values of cµPO2 and mµPO2 only declined slightly.
The loss in renal function can therefore probably not be attrib-
uted to hypoxia. Furthermore, there was no significant evi-
dence of intrarenal redistribution of oxygen during
endotoxemia as could be expected with redistribution in blood
flow. However, a significant redistribution of oxygen during
resuscitation could be observed.
Acute renal failure in sepsis is considered, at least in part, the
result of renal ischemia. That is why restoration of adequate
RBF by fluid resuscitation should therefore be the primary
means of renal protection in critically ill patients. There are few
data on the influence of fluid resuscitation on tissue oxygena-
tion [38]. Fluid resuscitation with HES200/0.5 (HES-STERIL®
6%) was successful in correcting intestinal mucosal µPO2,
but not in normalizing serosal µPO2 in a normodynamic, low-
dose endotoxic pig model [23]. In our model, fluid resuscita-
tion was associated with oxygen redistribution. This
redistribution occurred regardless of the type of used fluid and
was smallest, although significant, for HES130/0.4. In the
HES200/0.5 group both the cµPO2 and mµPO2 increased,
and this may most probably be explained by an increase in cor-
tical and medullary blood flow. When Ringer's lactate was
used for resuscitation, the cµPO2 decreased whereas the
mµPO2 was rather unaffected. A possible explanation of the
decrease in PO2 in the cortex might be due to an increase in
oxygen-consuming reabsorption of sodium in the cortical col-
lecting tubules following an increase in the glomerular filtration
rate.
In our study all resuscitation fluids were able to normalize the
RBF and oxygen delivery. In the only comparable study the gel-
atin-based resuscitation fluid Haemaccel® was able to restore
reduced oxygen delivery during endotoxemia; the oxygen con-
sumption was unaffected [39]. We observed the same effects
for HES130/0.4. The application of HES200/0.5 and Ringer's
lactate, however, was accompanied by a significant increase
in oxygen consumption. Based on the current data we can only
speculate on the exact reason(s) why both these fluids signif-
icantly increased the renal oxygen consumption compared
with baseline values in contrast to HES130/0.4. To reach our
chosen resuscitation endpoint (a plateau in RBF) higher vol-
umes of HES200/0.5 and Ringer's lactate where needed,
resulting in both a higher volume load and a higher total
sodium load. Moreover, systemic hemodynamic parametersCritical Care    Vol 10 No 3    Johannes et al.
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were better restored with HES200/0.5 and Ringer's lactate,
accompanied by a significant increase in RBF. These factors
are all known to influence renal oxygen consumption [40-42].
The increase in renal oxygen consumption was accompanied
by an increase in oxygen extraction, and therefore a decrease
in renal venous PO2, for HES200/0.5 and Ringer's lactate. A
point of interest from Figure 6 is that the VO2/TNa+ ratio has the
tendency to increase more in the case of HES200/0.5 and
Ringer's lactate as compared with HES130/0.4. This indi-
cates that at least part of the oxygen consumption is used by
processes other than sodium reabsorption, or alternatively that
sodium reabsorption is energetically less effective (higher oxy-
gen cost).
The glomerular filtration rate as an index of kidney function
could be restored to baseline values regardless of the type of
resuscitation fluid. In two other studies the application of a col-
loid solution could not restore an endotoxemia-induced reduc-
tion in the glomerular filtration rate [32,39], although in our
model the fluid resuscitation with the aim of restoring RBF was
more aggressive using much higher volumes. The controversy
cannot be explained by the fact that we used creatinine clear-
ance as a marker for the glomerular filtration rate/acute renal
failure since Heemskerk and colleagues [39] also used creat-
inine while Heneka and colleagues [32] used inulin clearance.
In this respect it is interesting to note that markers for acute
renal failure that show a faster response, such as serum cysta-
tin C [43], recently became available and these markers could
be the better choice in acute models of kidney failure. It is dif-
ficult to arrive at a definitive conclusion regarding the safety of
hydroxyethyl starches in respect to renal function. As all fluids
restored kidney function during endotoxemia to the same
extent, and both crystalloid and colloid solutions increased
oxygen consumption during resuscitation, no conclusion can
be made in a decision between crystalloids and colloids.
HES130/0.4 was able, however, to restore renal function with
the least increase in the amount of renal work, as indicated by
unaffected renal oxygen consumption. Since under conditions
of critical oxygen supply to the tissue one strives to minimize
oxygen consumption [44-46], the latter could prove clinically
beneficial in more severe shock states.
Conclusion
The present study for the first time monitored simultaneously
and continuously renal cortical and medullary µPO2 and renal
oxygen consumption in a rat model of endotoxemia and resus-
citation. Our model was associated with an impaired kidney
function during endotoxemia. As only minor changes in renal
µPO2 and oxygen consumption could be observed during
endotoxemia, the loss of kidney function cannot be explained
by an oxygen deficiency. Regardless of the type of resuscita-
tion fluid, the renal blood flow and kidney function could be
restored to baseline values. Fluid resuscitation was associated
by a redistribution of oxygen, which showed different patterns
for the different compounds used. HES200/0.5 and Ringer's
lactate increased the renal oxygen consumption, in contrast to
HES130/0.4. It can therefore be concluded that fluid resusci-
tation using HES130/0.4 resuscitates the kidney without
increasing the renal work load. This could prove clinically sig-
nificant in conditions where one strives for oxygen consump-
tion as low as possible.
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